MORONCINI, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 6.169
EU - Europa 3.407
AS - Asia 2.579
SA - Sud America 816
AF - Africa 170
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.156
Nazione #
US - Stati Uniti d'America 6.041
SG - Singapore 920
IT - Italia 811
BR - Brasile 707
CN - Cina 580
DE - Germania 411
UA - Ucraina 408
RU - Federazione Russa 383
HK - Hong Kong 353
SE - Svezia 321
IE - Irlanda 304
VN - Vietnam 256
TR - Turchia 175
DK - Danimarca 149
GB - Regno Unito 135
FI - Finlandia 130
FR - Francia 105
CI - Costa d'Avorio 92
KR - Corea 80
CA - Canada 64
NL - Olanda 56
IN - India 55
PL - Polonia 51
AT - Austria 47
AR - Argentina 41
MX - Messico 41
JP - Giappone 29
MA - Marocco 29
ZA - Sudafrica 27
BD - Bangladesh 22
ID - Indonesia 22
BE - Belgio 18
EC - Ecuador 18
ES - Italia 17
CO - Colombia 13
PY - Paraguay 13
IQ - Iraq 11
IL - Israele 10
CL - Cile 8
LT - Lituania 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
PK - Pakistan 7
RO - Romania 7
TN - Tunisia 7
AU - Australia 6
UZ - Uzbekistan 6
VE - Venezuela 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
EE - Estonia 5
EG - Egitto 5
EU - Europa 5
MY - Malesia 5
CZ - Repubblica Ceca 4
JM - Giamaica 4
KW - Kuwait 4
NO - Norvegia 4
PE - Perù 4
PS - Palestinian Territory 4
PT - Portogallo 4
SA - Arabia Saudita 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
GT - Guatemala 3
HN - Honduras 3
JO - Giordania 3
NI - Nicaragua 3
PH - Filippine 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
LB - Libano 2
LU - Lussemburgo 2
NP - Nepal 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 13.144
Città #
Ashburn 709
Chandler 621
Singapore 573
Dallas 513
Jacksonville 426
Hong Kong 350
Fairfield 334
Dublin 299
Boardman 287
Des Moines 262
New York 197
Wilmington 191
Beijing 163
Woodbridge 155
Houston 151
Centro 149
Los Angeles 141
Munich 133
Seattle 133
Ann Arbor 115
Lawrence 108
Princeton 108
Abidjan 92
Ancona 92
Ho Chi Minh City 92
San Mateo 92
The Dalles 83
Moscow 82
Cambridge 80
Hefei 80
São Paulo 73
Chicago 61
Hanoi 60
Nuremberg 47
Redmond 45
Buffalo 43
Turin 39
London 38
Turku 38
Warsaw 37
San Diego 35
Marche 30
Tolentino 30
Rio de Janeiro 29
Shanghai 29
Milan 27
Salt Lake City 26
Mexico City 25
Montreal 25
Tokyo 23
Washington 23
Johannesburg 22
Santa Clara 22
Atlanta 21
Brasília 20
Helsinki 20
Vienna 20
Guangzhou 19
Rome 19
Denver 18
Orem 18
Poplar 18
Jesi 17
Stockholm 17
Belo Horizonte 16
Brooklyn 16
Amsterdam 15
Chennai 15
Columbus 15
Porto Alegre 15
Wuhan 15
Boston 14
Brussels 14
Pune 14
San Francisco 14
Phoenix 13
Sterling 13
Curitiba 12
Jiaxing 12
Falls Church 11
Kilburn 11
Ankara 10
Da Nang 9
Elk Grove Village 9
Frankfurt am Main 9
Manchester 9
Ottawa 9
Tampa 9
Belgrade 8
Bắc Ninh 8
Florence 8
Guarulhos 8
Haiphong 8
Izmir 8
Jinhua 8
Monte San Pietrangeli 8
Osimo 8
Charlotte 7
Contagem 7
Macerata 7
Totale 8.237
Nome #
Insights from comparison of serum IgG4 between T2-eosinophilic asthma and eosinophilic granulomatosis with polyangiitis/idiopathic hypereosinophilic syndrome 206
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 192
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 172
The value of admission Troponin I to predict outcomes in suspected infections in elderly patients admitted in Internal Medicine: results from the SOFA-T collaboration, a multi-center study 166
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 165
Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management 155
The first outstanding 50 years of “Università Politecnica delle Marche”: Research achievements in life sciences 154
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 153
Adalimumab modulates angiogenesis in psoriatic skin 150
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 148
Development of the optimal touchscreen interface for patients with scleroderma 140
Preface 139
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 139
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 135
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 135
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 133
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 132
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 131
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 130
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. 126
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 126
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 125
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 122
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 122
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 121
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 117
Hypothalamic-pituitary-adrenal axis disregulation in PrPC-null mice. 116
Biologics in inflammatory immune-mediated systemic diseases 116
SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine 114
Analysis of ATP8B4 F436L missense variant in a large systemic sclerosis cohort 113
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 111
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 109
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 108
Agonistic antibodies in systemic sclerosis 107
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 106
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 105
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 104
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 102
Echocardiographic predictors of mortality in intermediate-risk pulmonary embolism 101
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study 100
Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. 100
The Wnt signalling inhibitor gene, WIF1, is silenced in fibroblasts derived from Systemic Sclerosis patients: role of oxidative stress 100
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 100
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin 99
History and scientific production of clinica medica and clinica ematologica in ancona 99
BIOLOGIC THERAPY IN INFLAMMATORY IMMUNOMEDIATED SYSTEMIC DISEASES: SAFETY PROFILE 99
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 98
MOTIF-GRAFTED HYBRID POLYPEPTIDES AND USES THEREOF 98
Mechanism of action of agonistic PDGFR auto-antibodies isolated from scleroderma patients 98
Pathogenic autoantibodies in systemic sclerosis 96
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 96
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 96
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach 96
Risk prediction of clinical adverse outcomes with machine learning in a cohort of critically ill patients with atrial fibrillation 96
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 95
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 95
Reactivation of Hepatitis B Virus Infection Associated with Anti-Tumor Necrosis Factor-α Therapy 94
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 94
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 93
Update of EULAR recommendations for the treatment of systemic sclerosis 93
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 93
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 92
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 91
Putative functional pathogenic autoantibodies in systemic sclerosis 91
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 90
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 90
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 89
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 88
Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress 88
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 86
Role of viral infections in the etiopathogenesis of systemic sclerosis 85
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance 85
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 84
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 84
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 84
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 84
Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin. 84
Clinical method applied to focused ultrasound: The case of wells’ score and echocardiography in the emergency department: A systematic review and a meta-analysis 84
Detection of typical and atypical BSE and scrapie prion strains by prion protein motif-grafted antibodies. 83
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 82
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways 82
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 82
Delection of typical and atypical bovine spongiform encephalopathy and scraipe prion strains by prion protein motif-grafted antibodies 81
Development of A Solid Phase Binding Assay For Detection of Conformational Anti-PDGFR Autoantibodies In the Serum of Patients Affected By Scleroderma 81
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 81
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 80
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 80
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 80
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 77
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 77
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 76
Reply 76
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 76
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 75
Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc 75
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 75
Letter to the Editor. Reply to Magalon J et al. (CT-1406) 74
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. 74
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 74
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 73
Totale 10.467
Categoria #
all - tutte 67.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021897 0 0 0 0 0 98 177 104 162 129 152 75
2021/2022865 44 190 23 29 22 43 20 53 83 57 125 176
2022/20231.821 148 189 128 162 113 403 9 101 382 24 122 40
2023/20241.153 163 38 66 138 167 233 21 51 11 82 57 126
2024/20252.871 319 259 75 48 128 119 345 128 585 190 282 393
2025/20263.894 581 639 650 913 979 132 0 0 0 0 0 0
Totale 13.552